Selecting patients with cisplatin-resistant germ cell tumors for high-dose chemotherapy

Editorial

R J Motzer. J Clin Oncol. 1996 Oct.

. 1996 Oct;14(10):2625-6.

doi: 10.1200/JCO.1996.14.10.2625.

No abstract available

Comment on

Treatment of germ cell cancer with two cycles of high-dose ifosfamide, carboplatin, and etoposide with autologous stem-cell support.
Margolin K, Doroshow JH, Ahn C, Hamasaki V, Leong L, Morgan R, Raschko J, Shibata S, Somlo G, Tetef M. Margolin K, et al. J Clin Oncol. 1996 Oct;14(10):2631-7. doi: 10.1200/JCO.1996.14.10.2631. J Clin Oncol. 1996. PMID: 8874321
High-dose chemotherapy as salvage treatment in germ cell tumors: a multivariate analysis of prognostic variables.
Beyer J, Kramar A, Mandanas R, Linkesch W, Greinix A, Droz JP, Pico JL, Diehl A, Bokemeyer C, Schmoll HJ, Nichols CR, Einhorn LH, Siegert W. Beyer J, et al. J Clin Oncol. 1996 Oct;14(10):2638-45. doi: 10.1200/JCO.1996.14.10.2638. J Clin Oncol. 1996. PMID: 8874322